Short-course neoadjuvant in situ vaccination for murine melanoma

BACKGROUND: Surgical resection remains an important component of multimodality treatment for most solid tumors. Neoadjuvant immunotherapy has several potential advantages, including in-situ tumor vaccination and pathologic assessment of response in the surgical specimen. We previously described an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiken, Taylor J, Komjathy, David, Rodriguez, Matthew, Stuckwisch, Ashley, Feils, Arika, Subbotin, Vladimir, Birstler, Jen, Gillies, Stephen D, Rakhmilevich, Alexander L, Erbe, Amy K, Sondel, Paul M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765065/
https://www.ncbi.nlm.nih.gov/pubmed/35039460
http://dx.doi.org/10.1136/jitc-2021-003586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765065/
https://www.ncbi.nlm.nih.gov/pubmed/35039460
http://dx.doi.org/10.1136/jitc-2021-003586

Ejemplares similares